A citation-based method for searching scientific literature

Thomas A Wynn. J Exp Med 2011
Times Cited: 747







List of co-cited articles
533 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Idiopathic pulmonary fibrosis.
Luca Richeldi, Harold R Collard, Mark G Jones. Lancet 2017
594
18

Idiopathic pulmonary fibrosis.
Talmadge E King, Annie Pardo, Moisés Selman. Lancet 2011
15

Idiopathic Pulmonary Fibrosis.
David J Lederer, Fernando J Martinez. N Engl J Med 2018
575
13

Simple method of estimating severity of pulmonary fibrosis on a numerical scale.
T Ashcroft, J M Simpson, V Timbrell. J Clin Pathol 1988
963
11

An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.
Ganesh Raghu, Harold R Collard, Jim J Egan, Fernando J Martinez, Juergen Behr, Kevin K Brown, Thomas V Colby, Jean-François Cordier, Kevin R Flaherty, Joseph A Lasky,[...]. Am J Respir Crit Care Med 2011
11


Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis.
Luca Richeldi, Roland M du Bois, Ganesh Raghu, Arata Azuma, Kevin K Brown, Ulrich Costabel, Vincent Cottin, Kevin R Flaherty, David M Hansell, Yoshikazu Inoue,[...]. N Engl J Med 2014
11

Idiopathic pulmonary fibrosis.
Fernando J Martinez, Harold R Collard, Annie Pardo, Ganesh Raghu, Luca Richeldi, Moises Selman, Jeffrey J Swigris, Hiroyuki Taniguchi, Athol U Wells. Nat Rev Dis Primers 2017
390
11

Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.
Ganesh Raghu, Martine Remy-Jardin, Jeffrey L Myers, Luca Richeldi, Christopher J Ryerson, David J Lederer, Juergen Behr, Vincent Cottin, Sonye K Danoff, Ferran Morell,[...]. Am J Respir Crit Care Med 2018
10

A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.
Talmadge E King, Williamson Z Bradford, Socorro Castro-Bernardini, Elizabeth A Fagan, Ian Glaspole, Marilyn K Glassberg, Eduard Gorina, Peter M Hopkins, David Kardatzke, Lisa Lancaster,[...]. N Engl J Med 2014
9

Mechanisms of fibrosis: therapeutic translation for fibrotic disease.
Thomas A Wynn, Thirumalai R Ramalingam. Nat Med 2012
8


Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy.
Peter M George, Athol U Wells, R Gisli Jenkins. Lancet Respir Med 2020
435
7

Developmental pathways in the pathogenesis of lung fibrosis.
Diptiman Chanda, Eva Otoupalova, Samuel R Smith, Thomas Volckaert, Stijn P De Langhe, Victor J Thannickal. Mol Aspects Med 2019
114
7

Molecular and cellular mechanisms of pulmonary fibrosis.
Nevins W Todd, Irina G Luzina, Sergei P Atamas. Fibrogenesis Tissue Repair 2012
231
6

The impact of TGF-β on lung fibrosis: from targeting to biomarkers.
Isis E Fernandez, Oliver Eickelberg. Proc Am Thorac Soc 2012
378
6


Mechanisms of pulmonary fibrosis.
Victor J Thannickal, Galen B Toews, Eric S White, Joseph P Lynch, Fernando J Martinez. Annu Rev Med 2004
459
6

Pathogenesis of idiopathic pulmonary fibrosis.
Paul J Wolters, Harold R Collard, Kirk D Jones. Annu Rev Pathol 2014
412
6

Pulmonary Macrophages: A New Therapeutic Pathway in Fibrosing Lung Disease?
Adam J Byrne, Toby M Maher, Clare M Lloyd. Trends Mol Med 2016
154
6

Inflammation and immunity in IPF pathogenesis and treatment.
P Heukels, C C Moor, J H von der Thüsen, M S Wijsenbeek, M Kool. Respir Med 2019
104
6

Fibrotic disease and the T(H)1/T(H)2 paradigm.
Thomas A Wynn. Nat Rev Immunol 2004
6

Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review.
John Hutchinson, Andrew Fogarty, Richard Hubbard, Tricia McKeever. Eur Respir J 2015
380
6


Idiopathic pulmonary fibrosis in US Medicare beneficiaries aged 65 years and older: incidence, prevalence, and survival, 2001-11.
Ganesh Raghu, Shih-Yin Chen, Wei-Shi Yeh, Brad Maroni, Qian Li, Yuan-Chi Lee, Harold R Collard. Lancet Respir Med 2014
335
5

TGF-β: the master regulator of fibrosis.
Xiao-Ming Meng, David J Nikolic-Paterson, Hui Yao Lan. Nat Rev Nephrol 2016
5

Silicosis.
Chi Chiu Leung, Ignatius Tak Sun Yu, Weihong Chen. Lancet 2012
552
5

Emerging therapies for idiopathic pulmonary fibrosis, a progressive age-related disease.
Ana L Mora, Mauricio Rojas, Annie Pardo, Moises Selman. Nat Rev Drug Discov 2017
151
5

M2 macrophages promote myofibroblast differentiation of LR-MSCs and are associated with pulmonary fibrogenesis.
Jiwei Hou, Jingyan Shi, Ling Chen, Zhongyang Lv, Xiang Chen, Honghui Cao, Zou Xiang, Xiaodong Han. Cell Commun Signal 2018
57
8

Multiple stromal populations contribute to pulmonary fibrosis without evidence for epithelial to mesenchymal transition.
Jason R Rock, Christina E Barkauskas, Michael J Cronce, Yan Xue, Jeffrey R Harris, Jiurong Liang, Paul W Noble, Brigid L M Hogan. Proc Natl Acad Sci U S A 2011
623
5

Is idiopathic pulmonary fibrosis an environmental disease?
Varsha S Taskar, David B Coultas. Proc Am Thorac Soc 2006
203
5

Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis.
Lutz Wollin, Eva Wex, Alexander Pautsch, Gisela Schnapp, Katrin E Hostettler, Susanne Stowasser, Martin Kolb. Eur Respir J 2015
393
5

Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification.
A L Katzenstein, J L Myers. Am J Respir Crit Care Med 1998
940
5

Nintedanib in Progressive Fibrosing Interstitial Lung Diseases.
Kevin R Flaherty, Athol U Wells, Vincent Cottin, Anand Devaraj, Simon L F Walsh, Yoshikazu Inoue, Luca Richeldi, Martin Kolb, Kay Tetzlaff, Susanne Stowasser,[...]. N Engl J Med 2019
549
5

Standardized quantification of pulmonary fibrosis in histological samples.
Ralf-Harto Hübner, Wolfram Gitter, Nour Eddine El Mokhtari, Micaela Mathiak, Marcus Both, Hendrik Bolte, Sandra Freitag-Wolf, Burkhard Bewig. Biotechniques 2008
297
5

Pulmonary fibrosis: pathogenesis, etiology and regulation.
M S Wilson, T A Wynn. Mucosal Immunol 2009
449
5

Single-Cell Transcriptomic Analysis of Human Lung Provides Insights into the Pathobiology of Pulmonary Fibrosis.
Paul A Reyfman, James M Walter, Nikita Joshi, Kishore R Anekalla, Alexandra C McQuattie-Pimentel, Stephen Chiu, Ramiro Fernandez, Mahzad Akbarpour, Ching-I Chen, Ziyou Ren,[...]. Am J Respir Crit Care Med 2019
424
5

Mechanisms of alveolar epithelial injury, repair, and fibrosis.
Rachel C Chambers, Paul F Mercer. Ann Am Thorac Soc 2015
91
5

Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis.
Ganesh Raghu, Kevin J Anstrom, Talmadge E King, Joseph A Lasky, Fernando J Martinez. N Engl J Med 2012
932
5

Macrophages in Tissue Repair, Regeneration, and Fibrosis.
Thomas A Wynn, Kevin M Vannella. Immunity 2016
5

Incidence and prevalence of idiopathic pulmonary fibrosis.
Ganesh Raghu, Derek Weycker, John Edelsberg, Williamson Z Bradford, Gerry Oster. Am J Respir Crit Care Med 2006
830
5

Bleomycin-induced interstitial pulmonary disease in the nude, athymic mouse.
S V Szapiel, N A Elson, J D Fulmer, G W Hunninghake, R G Crystal. Am Rev Respir Dis 1979
316
4

Bleomycin in the setting of lung fibrosis induction: From biological mechanisms to counteractions.
Veronica Della Latta, A Cecchettini, S Del Ry, M A Morales. Pharmacol Res 2015
191
4

NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury.
Louise Hecker, Ragini Vittal, Tamara Jones, Rajesh Jagirdar, Tracy R Luckhardt, Jeffrey C Horowitz, Subramaniam Pennathur, Fernando J Martinez, Victor J Thannickal. Nat Med 2009
592
4

An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias.
William D Travis, Ulrich Costabel, David M Hansell, Talmadge E King, David A Lynch, Andrew G Nicholson, Christopher J Ryerson, Jay H Ryu, Moisés Selman, Athol U Wells,[...]. Am J Respir Crit Care Med 2013
4

Molecular mechanisms of epithelial-mesenchymal transition.
Samy Lamouille, Jian Xu, Rik Derynck. Nat Rev Mol Cell Biol 2014
4

Classification and natural history of the idiopathic interstitial pneumonias.
Dong Soon Kim, Harold R Collard, Talmadge E King. Proc Am Thorac Soc 2006
263
4

Immune Mechanisms in Pulmonary Fibrosis.
Saeed Kolahian, Isis E Fernandez, Oliver Eickelberg, Dominik Hartl. Am J Respir Cell Mol Biol 2016
133
4

WNT1-inducible signaling protein-1 mediates pulmonary fibrosis in mice and is upregulated in humans with idiopathic pulmonary fibrosis.
Melanie Königshoff, Monika Kramer, Nisha Balsara, Jochen Wilhelm, Oana Veronica Amarie, Andreas Jahn, Frank Rose, Ludger Fink, Werner Seeger, Liliana Schaefer,[...]. J Clin Invest 2009
397
4

Organ and tissue fibrosis: Molecular signals, cellular mechanisms and translational implications.
Ralf Weiskirchen, Sabine Weiskirchen, Frank Tacke. Mol Aspects Med 2019
181
4


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.